Antimicrobial Agents and Chemotherapy · 2010 · 31 citations · 27 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceDrug DiscoveryMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsMultidrug ResistanceEscherichia ColiFluoroquinolone AntibioticsFluoroquinolone Resistance MechanismsNovel Antibacterial Drug DiscoveryQuinolone Topoisomerase InhibitorsTopoisomerase ActivityTopoisomerase I InhibitorsTreatment Of Bacterial Resistance
Bacterial resistance presents a difficult issue for fluoroquinolone treatment of bacterial infections. In previous work, we reported that 8-methoxy-quinazoline-2,4-diones are active against quinolone-resistant mutants of Escherichia coli. Here, we demonstrate the activity of a representative 8-methoxy-quinazoline-2,4-dione against quinolone-resistant gyrases. Furthermore, 8-methoxy-quinazoline-2,4-dione and other diones are shown to inhibit Staphylococcus aureus gyrase and topoisomerase IV with similar degrees of efficacy, suggesting that the diones might act as dual-targeting agents against S. aureus.
27
Gary Taubes · Science · 2008 · 749 citations
[17]Gene splicing by overlap extension
Robert M. Horton, Steffan N. Ho, Jeffrey K. Pullen et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1993 · 465 citations
Quinolone antimicrobial agents
International Journal of Biochemistry · 1989 · 407 citations